Results 41 to 50 of about 70,027 (183)

Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition

open access: yesJournal of Inflammation
Background Metastatic pancreatic adenocarcinoma has a 5-year survival of only 3%. Neutrophil extracellular traps are formed when neutrophils expel their intracellular contents and have been intricately linked to metastases.
Britney Niemann   +7 more
doaj   +1 more source

The place of hydroxychloroquine in modern dermatology

open access: yesPrzegląd Dermatologiczny, 2021
Hydroxychloroquine has been known since the 1940s. It was initially used to treat malaria. Currently, it has a well-established position in the treatment of lupus erythematosus. The knowledge about its benefits is increasing over time.
Aleksandra Dańczak-Pazdrowska   +1 more
doaj   +1 more source

Hydroxychloroquine and IIH

open access: yes, 2022
Dr.
Andrew G. Lee, MD
core  

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine [PDF]

open access: yes, 2018
We read the article by McGill and Ambrose on lupus in young people with interest.1 They reiterate that patients should receive retinal screening after 5 years of exposure to hydroxychloroquine.1 It is estimated that there may be up to 161 000 users of ...
Yusuf, Imran H.   +3 more
core   +1 more source

Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundCardiovascular disease (CVD) is the leading cause of death in rheumatoid arthritis (RA) patients. This study is the first to report the association of hydroxychloroquine (an antirheumatic medication that has been associated with decreased risk ...
Tarun S. Sharma   +6 more
doaj   +1 more source

Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice

open access: yesScientific Reports, 2021
Hydroxychloroquine has recently received attention as a treatment for COVID-19. However, it may prolong the QTc interval. Furthermore, when hydroxychloroquine is administered concomitantly with other drugs, it can exacerbate the risk of QT prolongation ...
Byung Jin Choi   +8 more
doaj   +1 more source

Use of hydroxychloroquine to prevent SARS-CoV-2 infection and treat mild COVID-19: a systematic review and meta-analysis

open access: yesJornal Brasileiro de Pneumologia, 2021
Objective: Chloroquine or hydroxychloroquine has demonstrated no effect on the treatment of hospitalized COVID-19 patients. This study aimed to answer questions related to the use of hydroxychloroquine for pre-exposure or post-exposure prophylaxis of ...
Suzana E Tanni   +3 more
doaj   +2 more sources

Demographic and clinical characteristics associated with screening practices for hydroxychloroquine retinopathy

open access: yesScientific Reports
In this nationwide population-based cohort study, we investigated the demographic and clinical characteristics associated with hydroxychloroquine retinopathy screening using the National Health Insurance Review and Assessment database in South Korea ...
Jiyeong Kim   +4 more
doaj   +1 more source

Effect of Hydroxychloroquine on the Retinal Layers: A Quantitative Evaluation with Spectral-Domain Optical Coherence Tomography

open access: yesJournal of Ophthalmology, 2016
Purpose. To evaluate the effect of hydroxychloroquine on retinal pigment epithelium- (RPE-) Bruch’s membrane complex, photoreceptor outer segment, and macular ganglion cell-inner plexiform layer (GCIPL) thicknesses using spectral-domain optical coherence
Hasim Uslu   +7 more
doaj   +1 more source

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study

open access: yesInternational Journal of Infectious Diseases, 2021
Objective: Hydroxychloroquine has been proposed as a primary prophylactic agent against coronavirus disease 2019 (COVID-19). This study aimed to investigate if patients treated with hydroxychloroquine for a non-COVID-19 indication had a lower risk of ...
Peter Kamstrup   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy